Memo is located both in the nucleus and cytoplasm [11, 12], and its expression has been found to be increased in >40% of primary breast tumors, where its cytoplasmic localization correlated with aggressive disease parameters, such as Luminal B subtype, early-distant recurrence, and death [9]. This evidence concerns the gene MEMO1 and breast neoplasm.